» Articles » PMID: 1409681

Quinolone Binding to DNA is Mediated by Magnesium Ions

Overview
Specialty Science
Date 1992 Oct 15
PMID 1409681
Citations 30
Authors
Affiliations
Soon will be listed here.
Abstract

The binding of plasmid DNA to norfloxacin, a quinolone antibacterial agent, was investigated by fluorescence, electrophoretic DNA unwinding, and affinity chromatography techniques. The amount of quinolone bound to DNA was modulated by the concentration of Mg2+. No interaction was evident in the absence of Mg2+ or in the presence of an excess of Mg2+, whereas maximum binding was observed at a Mg2+ concentration of 1-2 mM. The experimental data can be fitted to the formation of three types of Mg adducts: a binary adduct with norfloxacin and Mg2+, a binary adduct with DNA and Mg2+, and a ternary adduct with quinolone, plasmid, and Mg2+. We propose a model for the ternary complex, in which Mg acts as a bridge between the phosphate groups of the nucleic acid and the carbonyl and carboxyl moieties of norfloxacin. Additional stabilization may arise from stacking interactions between the condensed rings of the drug and DNA bases (especially guanine and adenine), which may account for the preference exhibited by quinolones for single-stranded and purine-rich regions of nucleic acids. Other possible biochemical pathways of drug action are suggested by the observation that norfloxacin binds Mg2+ under conditions that are close to physiological.

Citing Articles

Fluoroquinolone-specific resistance trajectories in E. coli and their dependence on the SOS-response.

Teichmann L, Luitwieler S, Bengtsson-Palme J, Ter Kuile B BMC Microbiol. 2025; 25(1):37.

PMID: 39838279 PMC: 11748515. DOI: 10.1186/s12866-025-03771-5.


Gyrase and Topoisomerase IV: Recycling Old Targets for New Antibacterials to Combat Fluoroquinolone Resistance.

Collins J, Osheroff N ACS Infect Dis. 2024; 10(4):1097-1115.

PMID: 38564341 PMC: 11019561. DOI: 10.1021/acsinfecdis.4c00128.


Ciprofloxacin and levofloxacin attenuate microglia inflammatory response via TLR4/NF-kB pathway.

Zusso M, Lunardi V, Franceschini D, Pagetta A, Lo R, Stifani S J Neuroinflammation. 2019; 16(1):148.

PMID: 31319868 PMC: 6637517. DOI: 10.1186/s12974-019-1538-9.


Novel N-1 substituted fluoroquinolones inhibit human topoisomerase I activity and exhibit anti-proliferative activity.

Oppegard L, Delgado J, Kulkarni C, Towle T, Hart D, Williams B Invest New Drugs. 2018; 37(2):378-383.

PMID: 30198058 PMC: 6409185. DOI: 10.1007/s10637-018-0666-x.


Topoisomerases as anticancer targets.

Delgado J, Hsieh C, Chan N, Hiasa H Biochem J. 2018; 475(2):373-398.

PMID: 29363591 PMC: 6110615. DOI: 10.1042/BCJ20160583.


References
1.
Holler E, Holmquist B, Vallee B, Taneja K, Zamecnik P . Circular dichroism and ordered structure of bisnucleoside oligophosphates and their Zn2+ and Mg2+ complexes. Biochemistry. 1983; 22(21):4924-33. DOI: 10.1021/bi00290a008. View

2.
LITMAN R . A deoxyribonucleic acid polymerase from Micrococcus luteus (Micrococcus lysodeikticus) isolated on deoxyribonucleic acid-cellulose. J Biol Chem. 1968; 243(23):6222-33. View

3.
Gellert M, Mizuuchi K, ODea M, NASH H . DNA gyrase: an enzyme that introduces superhelical turns into DNA. Proc Natl Acad Sci U S A. 1976; 73(11):3872-6. PMC: 431247. DOI: 10.1073/pnas.73.11.3872. View

4.
Sugino A, Peebles C, Kreuzer K, Cozzarelli N . Mechanism of action of nalidixic acid: purification of Escherichia coli nalA gene product and its relationship to DNA gyrase and a novel nicking-closing enzyme. Proc Natl Acad Sci U S A. 1977; 74(11):4767-71. PMC: 432036. DOI: 10.1073/pnas.74.11.4767. View

5.
Gellert M, Mizuuchi K, ODea M, Itoh T, TOMIZAWA J . Nalidixic acid resistance: a second genetic character involved in DNA gyrase activity. Proc Natl Acad Sci U S A. 1977; 74(11):4772-6. PMC: 432037. DOI: 10.1073/pnas.74.11.4772. View